Computational drug repositioning leverages computational technology and high volume of biomedical data to identify new indications for existing drugs. (FDA) CZC-25146 approved breast cancer drugs. We then converted and represented these profiles in Semantic Web notations which support automated semantic inference. We successfully evaluated the performance and efficacy of the breast cancer drug pharmacogenomics profiles… Continue reading Computational drug repositioning leverages computational technology and high volume of biomedical